In this Cancer Matters podcast, Dr Bill Nelson and Dr Ashwani Rajput, the Director of the Kimmel Cancer Center in the National Capital Region, discuss how the Johns Hopkins Health System will deal with a backlog of cancer surgeries that were delayed by COVID-19.
The Cancer Matters podcast returns with Dr Bill Nelson and Dr Carol Ann Huff explaining how the Johns Hopkins Kimmel Cancer Center is handling the COVID-19 pandemic and adjusting to treat patients who contract the virus.
Johns Hopkins Kimmel Cancer Center Director William Nelson, MD, PhD, spoke with The Cancer Letter about how our cancer center is managing the COVID-19 pandemic. You can read the conversation here: http://bit.ly/clnelson
In the latest Cancer Matters podcast, Dr Bill Nelson talks with Dr Panagis Galiatsatos about the dangers of smoking or vaping and the science behind nicotine addiction.
In this Cancer Matters podcast, Dr Bill Nelson talks to Jeanine Pennington, Portfolio Director for Johns Hopkins Technology Ventures, about the assistance they provide to researchers in finding partnerships, managing the legal and regulatory process and, in some cases, helping to start companies to bring the discoveries and innovations found in the lab to patients […]
In the latest Cancer Matters podcast, Dr Bill Nelson and Dr Jonathan Powell discuss how T cells activated from the immune system are being used to fight cancer.
In this Cancer Matters podcast, Dr Bill Nelson and Dr Cynthia Zahnow discuss how her experience as a breast cancer survivor informs her research into examining a potential link between alcohol consumption and breast cancer.
In this Cancer Matters podcast, Dr Bill Nelson speaks with thoracic surgeon Dr Stephen Broderick about the latest developments in lung cancer care that have made lung surgery less debilitating and improved patient outcomes.
In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Valerie Lee about the treatment of anal and rectal cancers.
In this week's Cancer Matters podcast, Dr Bill Nelson speaks with Dr Venu Raman about his work to develop a cancer drug targeting a gene that stabilizes tumors.